Refractory congestive heart failure: when the solution is outside the heart

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Refractory congestive heart failure (CHF) presents limited treatment options and a poor prognosis.
• Continuous ambulatory peritoneal dialysis (CAPD) is an emerging therapeutic alternative for select CHF patients.
• Effective management of fluid overload is critical in patients with cardiorenal syndrome.

Observation:

• A case study of an elderly patient with severe left ventricular dysfunction, mitral, and tricuspid regurgitation experiencing recurrent anasarca.
• The patient was enrolled in a continuous ambulatory peritoneal dialysis (CAPD) program.
• Despite persistent cardiac issues, the patient showed significant clinical and biochemical improvement post-CAPD initiation.

Findings:

• Continuous ambulatory peritoneal dialysis (CAPD) led to marked clinical improvement, including reduced edema.
• Biochemical markers improved, indicating better fluid and electrolyte balance.
• CAPD demonstrated superior sodium removal compared to conventional diuretic strategies.

Implications:

• Continuous ambulatory peritoneal dialysis (CAPD) is a valuable tool for managing volume excess in refractory heart failure with renal failure.
• This approach can improve quality of life and reduce hospitalizations in a challenging patient population.
• Further research into CAPD's role in cardiorenal syndrome is warranted.